BioSpace News Archive

Talaris Therapeutics, Inc.today announced the initiation of the company’s Phase 2 FREEDOM-2 study.

NovaBiotics Ltd announces that they will present two posters highlighting new preclinical data on cysteamine at the North American Cystic Fibrosis Conference taking place virtually from November 2-5, 2021.

Oramed Pharmaceuticals Inc. today announced that its majority-owned subsidiary, Oravax Medical Inc. ( www.ora-vax.com ), has received clearance from the South African Health Products Regulatory Authority to commence patient enrollment in a first in human, Phase 1 clinical trial, for its oral COVID-19 vaccine and preparations to begin the trials are now underway.

Rapid Micro Biosystems, Inc. today announced that it will be participating in the Stifel 2021 Virtual Healthcare Conference on Tuesday, November 16, 2021.

Ardelyx, Inc.today announced that four tenapanor abstracts have been accepted for presentation at the American Society of Nephrology Kidney Week 2021 (ASN Kidney Week), which is taking place virtually November 4 - November 7, 2021.

Bioventus Inc. has completed the acquisition of Misonix, Inc. (“Misonix”), a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that are designed to enhance clinical outcomes, for cash and common stock.

Schrödinger (Nasdaq: SDGR), today announced that it will host a conference call and webcast on Wednesday, November 10, 2021, at 4:30 p.m. ET to discuss third quarter 2021 financial results and provide an update on its business.

Vyaire Medical, today announced the availability of SuperNO2VA™ Et, a mask that utilizes breakthrough technology to stent the airway open, thus avoiding airway collapse while accurately monitoring end tidal carbon dioxide (EtCO2), which is particularly important for high-risk patients.

Dr. Reddy’s Laboratories Ltd. today announced the launch of Ephedrine Sulfate Injection USP, 50 mg/mL, a therapeutic equivalent generic version of Akovaz® (ephedrine sulfate injection) Injection, 50 mg/mL approved by the U.S. Food and Drug Administration (USFDA).

Immunovia AB announced that Thomas King, MD, PhD, Medical Director of Immunovia, Inc. was invited to present to the U.S. National Cancer Institute Pancreatic Cancer Detection Consortium as a keynote speaker at their upcoming Steering Committee Meeting, taking place virtually on December 13-14, 2021.